Edap Tms (NASDAQ:EDAP) Stock Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

Edap Tms S.A. (NASDAQ:EDAP)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.10 and traded as high as $3.44. Edap Tms shares last traded at $3.40, with a volume of 57,290 shares trading hands.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on EDAP shares. Jefferies Financial Group reissued a “hold” rating and set a $2.00 price objective on shares of Edap Tms in a research report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a research note on Monday, December 29th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $8.50.

Edap Tms Stock Up 3.3%

The business has a fifty day moving average of $2.49 and a 200 day moving average of $2.10. The company has a market capitalization of $127.13 million, a PE ratio of -5.96 and a beta of -0.26. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.04.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.11. The company had revenue of $16.29 million for the quarter, compared to analyst estimates of $15.05 million. Edap Tms had a negative net margin of 30.95% and a negative return on equity of 61.60%. Equities research analysts anticipate that Edap Tms S.A. will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

A hedge fund recently bought a new stake in Edap Tms stock. Simplicity Wealth LLC bought a new position in shares of Edap Tms S.A. (NASDAQ:EDAP) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 32,548 shares of the medical equipment provider’s stock, valued at approximately $54,000. Simplicity Wealth LLC owned about 0.09% of Edap Tms as of its most recent SEC filing. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.